2020
DOI: 10.1016/j.ajo.2019.12.022
|View full text |Cite
|
Sign up to set email alerts
|

Presentation and Progression of Papilledema in Cerebral Venous Sinus Thrombosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
32
0
3

Year Published

2021
2021
2023
2023

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 28 publications
(36 citation statements)
references
References 22 publications
1
32
0
3
Order By: Relevance
“…e-supplement Table 3 compares in detail demographics and clinical characteristics of patients in our series with important published literature. [ 1 4 11 12 13 15 16 ] We describe in brief important observations in our study as compared to prior literature.…”
Section: Discussionmentioning
confidence: 98%
“…e-supplement Table 3 compares in detail demographics and clinical characteristics of patients in our series with important published literature. [ 1 4 11 12 13 15 16 ] We describe in brief important observations in our study as compared to prior literature.…”
Section: Discussionmentioning
confidence: 98%
“…Even though most patients have good final visual acuity, a significant proportion (40%) suffer permanent visual field deficits. The risk of visual field loss increases with more severe papilledema grade (Frisen grade >3) and cases with progression of papilledema [7]. Although D-dimer is widely used to exclude possible deep-vein thrombosis or pulmonary embolism, it has shown a low sensitivity and specificity as a predictive factor for CVST [8].…”
Section: Discussionmentioning
confidence: 99%
“…Even though head trauma accounts for only 1-3% of cases of this rare venous thromboembolic disease [4,7], it is important for physicians to raise awareness of the diagnosis of CVST if a patient with definite history of head trauma shows persistent or worsening neurological symptoms despite negative results on serial non-contrast cranial CT scans.…”
Section: Discussionmentioning
confidence: 99%
“…Papilledema 33,34 is the only objective clinical sign of intracranial hypertension. 35,36 Because the degree of papilledema at presentation is a reliable indicator of subsequent visual outcomes from secondary optic atrophy, [3][4][5][6][7][8][9] the severity of papilledema influences the management and the frequency of visual monitoring during follow-up of patients with elevated ICP. 37,38 Our simple binary classification of papilledema severity aimed at identification of patients with lower risk (mild to moderate papilledema) or higher risk (severe papilledema) of visual loss.…”
Section: Discussionmentioning
confidence: 99%